Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Global phase IV trial of Detrusitol SR 4 mg on Patient's Perception of Bladder Condition
2004-000996-33Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in overactive bladder (OAB) comparing Detrusitol SR 4 mg with Placebo (2 arms). Primary endpoint: Improvement in Patient's Perception of Bladder Condition at week 12. Started Jul 2004; status: completed.
02
Drugs
tolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2004-000996-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000996-33.